A new study, published in the European Journal of General Practice, examines the challenges and supporting factors that general practitioners (GPs) in Germany face when deprescribing antidepressants.
The researchers found that factors supporting GPs in deprescribing include effective communication with patients, assistance from pharmacists and digital tools, and a generally positive attitude toward deprescribing. What hinders deprescribing, the researchers found, includes limited time, insufficient collaboration with specialists, and a lack of supportive tools.
Jochen Vukas of the Institute of General Practice and Family Medicine at LMU University Hospital in Munich led the researchers. They identify areas for improvement to increase GP confidence in deprescribing:
“This study identified key barriers and facilitators influencing antidepressant deprescribing among GPs in Germany, contributing valuable insights into the behavioural factors shaping this process. Addressing time constraints, enhancing interdisciplinary collaboration, and integrating decision-support tools into clinical practice could facilitate deprescribing.”
You've landed on a MIA journalism article that is funded by MIA supporters. To read the full article, sign up as a MIA Supporter. All active donors get full access to all MIA content, and free passes to all Mad in America events.
Current MIA supporters can log in below.(If you can't afford to support MIA in this way, email us at [email protected] and we will provide you with access to all donor-supported content.)
